BusinessImmuron Reports Significant Alleviation of Colitis Symptoms in Preclinical ProgramBy Nasdaq OMXMay 8, 2018, 1:43 AM UTC
BusinessLyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel DiseaseBy Nasdaq OMXApr 23, 2018, 7:18 PM UTC
BusinessVitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100By Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessImmuron Commences US Non-Deal Institutional Investor RoadshowBy Nasdaq OMXAug 15, 2017, 1:15 PM UTC
